Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology

Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology

Alzheimer’s pathology can be assessed and defined via Aβ and tau biomarkers. The preclinical period of Alzheimer’s disease is long and lasts several decades. Although effective therapies to block pathological processes of Alzheimer’s disease are still lacking, downward trends in the incidence and pr...

Full description

Bibliographic Details
Main Author:	Pengxu Wei
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Biomedicines
Subjects:	Alzheimer’s disease dementia ultra-early screening cognitive decline
Online Access:	https://www.mdpi.com/2227-9059/11/5/1423

Similar Items

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
by: Adalberto Studart Neto, et al.

Demand Coupling Drives Neurodegeneration: A Model of Age-Related Cognitive Decline and Dementia
by: Josh Turknett, et al.
Published: (2022-09-01)

Adding cognition to AT(N) models improves prediction of cognitive and functional decline
by: Deirdre M. O'Shea, et al.
Published: (2021-01-01)

Cognitive Decline Detection for Alzheimer’s Disease Patients Through an Activity of Daily Living (ADL)
by: G. Palacios-Navarro, et al.
Published: (2022-01-01)

Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time
by: Marina Ávila-Villanueva, et al.
Published: (2017-11-01)

The efficacy and practicality of the Neurotrack Cognitive Battery assessment for utilization in clinical settings for the identification of cognitive decline in an older Japanese population
by: Jordan M. Glenn, et al.
Published: (2023-08-01)

Early Functional and Cognitive Declines Measured by Auditory-Evoked Cortical Potentials in Mice With Alzheimer’s Disease
by: Ling Mei, et al.
Published: (2021-09-01)

Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia
by: Ligia J. Dominguez, et al.
Published: (2021-11-01)

Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons
by: Sarah L. Booth, et al.
Published: (2022-01-01)

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
by: Sami Ouanes, et al.
Published: (2022-07-01)

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
by: Magdalena Mroczek, et al.
Published: (2022-03-01)

Differential diagnosis for cognitive decline in elderly
by: Om Prakash, et al.
Published: (2016-01-01)

The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence
by: Alina Mihaela Dimache, et al.
Published: (2021-06-01)

Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer’s disease
by: Yaqiong Xiao, et al.
Published: (2023-12-01)

The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design
by: Jared C. Roach, et al.
Published: (2022-01-01)

Cognitive performance before and after the onset of subjective cognitive decline in old age
by: Alexander Koppara, et al.
Published: (2015-06-01)

Early detection of cognitive decline in Alzheimer’s disease using eye tracking
by: Shin-ichi Tokushige, et al.
Published: (2023-03-01)

A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer’s disease (AD)
by: Miyako Tazaki
Published: (2024-02-01)

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer’s disease in patients with mild cognitive symptoms
by: Ida Arvidsson, et al.
Published: (2024-03-01)

Tooth loss and the risk of cognitive decline and dementia: A meta-analysis of cohort studies
by: Liqing Li, et al.
Published: (2023-04-01)

Neuropsychological Decline Stratifies Dementia Risk in Cognitively Unimpaired and Impaired Older Adults
by: Jean K. Ho, et al.
Published: (2022-07-01)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
by: Rebecca Langhough Koscik, et al.
Published: (2021-07-01)

Editorial: New management strategies for older adults with cognitive decline
by: Takao Yamasaki, et al.
Published: (2023-12-01)

Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review
by: Francisca Monteiro, et al.
Published: (2022-01-01)

The Potential role of marine derived food products on Alzheimer\'s disese and cognitive decline
by: Mahsan Assadi, et al.
Published: (2011-11-01)

Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive Decline
by: Kenichiro Sato, et al.
Published: (2022-05-01)

Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease
by: Reena T. Gottesman, et al.
Published: (2019-09-01)

A latent class analysis of cognitive decline in US adults, BRFSS 2015-2020
by: Ryan Snead, et al.
Published: (2022-08-01)

Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?
by: Michael Lassi, et al.
Published: (2023-01-01)

Early Secure Attachment as a Protective Factor Against Later Cognitive Decline and Dementia
by: Emilie Walsh, et al.
Published: (2019-07-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
by: Corinna M. Bauer, et al.
Published: (2018-02-01)

The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
by: Leticia Forny-Germano, et al.
Published: (2019-01-01)

Homebased screening for cognitive impairment due to dementia
by: T. Hansen, et al.
Published: (2022-06-01)

Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer’s disease
by: Liat Ben-Ami, et al.
Published: (2023-02-01)

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
by: Simon W. So, et al.
Published: (2023-05-01)

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum
by: Sylvain Lehmann, et al.
Published: (2023-12-01)

Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review
by: Chian Thong Chun, et al.
Published: (2021-11-01)

A Survey of Alzheimer’s Disease Early Diagnosis Methods for Cognitive Assessment
by: Juan Manuel Fernández Montenegro, et al.
Published: (2020-12-01)

Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years
by: Lucas Ronat, et al.
Published: (2024-02-01)

Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study
by: Takahiro Fukumoto, et al.
Published: (2022-12-01)